Biological evaluation of both enantiomers of fluoro-thalidomide using human myeloma cell line H929 and others

• Etsuko Tokunaga,

  Roles Data curation, Formal analysis, Investigation, Methodology, Writing – original draft, Writing – review & editing

  Affiliation Department of Nanopharmaceutical Sciences, Nagoya Institute of Technology, Nagoya, Japan

  ⨯
• Hidehiko Akiyama,

  Roles Data curation, Formal analysis, Methodology

  Affiliation Faculty of Medical Technology, Fujita Health University, Toyoake, Japan

  ⨯
• Vadim A. Soloshonok,

  Roles Visualization, Writing – review & editing

  Affiliations Department of Organic Chemistry I, Faculty of Chemistry, University of the Basque Country UPV/EHU, San Sebastián, Spain, IKERBASQUE, Basque Foundation for Science Maria Diaz de Haro, Bilbao, Spain

  ⨯
• Yuki Inoue,

  Roles Data curation, Formal analysis, Methodology

  Affiliation Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan

  ⨯
• Hideaki Hara,

  Roles Data curation, Formal analysis, Methodology

  Affiliation Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan

  ⨯
• Norio Shibata

  Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Visualization, Writing – original draft, Writing – review & editing

  * E-mail: nozshiba@nitech.ac.jp

  Affiliation Department of Nanopharmaceutical Sciences, Nagoya Institute of Technology, Nagoya, Japan

  http://orcid.org/0000-0002-3742-4064

  ⨯